-+ 0.00%
-+ 0.00%
-+ 0.00%

CORBUS PHARMACEUTICALS ANNOUNCES LAST PATIENT FIRST VISIT IN CANYON-1 STUDY OF CRB-913 FOR THE TREATMENT FOR OBESITY

Reuters·04/14/2026 12:00:06

Please log in to view news